Business Insider·· 11 天前AI 评分52
Business Insider记者在长寿药会议采访药企高管，梳理制药业对衰老干预的关注
I spent 3 days with pharma executives. They're suddenly taking longevity seriously.
AI 导读
Business Insider记者在波士顿参加为期3天的 ARDD 会议后发现，辉瑞、GSK、阿斯利康、诺华和礼来等药企高管正讨论衰老干预药物，FDA也首次参与会议，并表示计划明年发布临床试验指导意见。
来源：Business Insider · businessinsider.com